WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsUtah Medical Products Inc (UTMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 73711% more annual revenue ($28.43B vs $38.52M). UTMD leads profitability with a 29.3% profit margin vs 4.1%. UTMD trades at a lower P/E of 18.6x. MDLN earns a higher WallStSmart Score of 52/100 (C-).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

UTMD

Hold

48

out of 100

Grade: D+

Growth: 2.0Profit: 8.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.67

$24.25 discount

UndervaluedFair: $66.92Overvalued
UTMDSignificantly Overvalued (-173.3%)

Margin of Safety

-173.3%

Fair Value

$23.32

Current Price

$63.71

$40.39 premium

UndervaluedFair: $23.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

UTMD3 strengths · Avg: 9.0/10
Operating MarginProfitability
31.1%10/10

Strong operational efficiency at 31.1%

Profit MarginProfitability
29.3%9/10

Keeps 29 of every $100 in revenue as profit

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

UTMD4 concerns · Avg: 2.3/10
Market CapQuality
$204.39M3/10

Smaller company, higher risk/reward

PEG RatioValuation
4.252/10

Expensive relative to growth rate

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

EPS GrowthGrowth
-6.4%2/10

Earnings declined 6.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : UTMD

The strongest argument for UTMD centers on Operating Margin, Profit Margin, Price/Book. Profitability is solid with margins at 29.3% and operating margin at 31.1%.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : UTMD

The primary concerns for UTMD are Market Cap, PEG Ratio, Revenue Growth.

Key Dynamics to Monitor

MDLN profiles as a value stock while UTMD is a declining play — different risk/reward profiles.

MDLN is growing revenue faster at 14.8% — sustainability is the question.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLN scores higher overall (52/100 vs 48/100) and 14.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Utah Medical Products Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.

Want to dig deeper into these stocks?